高级检索
当前位置: 首页 > 详情页

Mometasone furoate nasal spray reduces symptoms and improves quality of life in Chinese patients with moderate to severe allergic rhinitis: a multicenter open-label study

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Inst Otolaryngol, Beijing TongRen Hosp,Key Lab Otolaryngol Head & N, Dept Otolaryngol Head & Neck Surg,Minist Educ, Beijing 100005, Peoples R China [2]Sun Yat Sen Univ, Otolaryngol Inst Hosp, Guangzhou 510275, Guangdong, Peoples R China [3]Sichuan Univ, W China Hosp, Dept Otolaryngol Head & Neck Surg, Chengdu 610064, Peoples R China [4]Sun Yat Sen Univ, Affiliated Hosp 3, Dept Otolaryngol Head & Neck Surg, Guangzhou 510275, Guangdong, Peoples R China [5]Zhejiang Univ, Affiliated Hosp 1, Dept Otolaryngol Head & Neck Surg, Hangzhou 310003, Zhejiang, Peoples R China [6]Zhejiang Univ, Affiliated Hosp 2, Dept Otolaryngol Head & Neck Surg, Hangzhou 310003, Zhejiang, Peoples R China [7]Fudan Univ, Eye & Ear Hosp, Dept Otolaryngol, Shanghai 200433, Peoples R China [8]Shanghai First Peoples Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China [9]Jiangsu Prov Hosp, Dept Otolaryngol, Nanjing, Peoples R China [10]Xinjiang Med Univ, Teaching Hosp 1, Dept Otolaryngol, Urumqi, Peoples R China
出处:
ISSN:

关键词: Allergic rhinitis mometasone furoate clinical efficacy quality of life safety

摘要:
Conclusion: mometasone furoate nasal spray (MFNS) can reduce the symptoms and improve quality of life in Chinese patients with moderate to severe allergic rhinitis (AR). Objective: To evaluate the effects of MF on symptoms and quality of life in Chinese patients with moderate to severe AR. Patients and methods: In a multicenter and open-label study, 500 patients with moderate to severe AR were enrolled and received MFNS 200 mu g once daily. We visited the patients four times (at baseline, and week 1, 2, and 4) to record symptom scores and the influence of AR on daytime activities and quality of sleep. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (Mini-RQLQ) and the Nocturnal Rhinoconjunctivitis Quality of Life Questionnaire (NRQLQ) were used in this study. Results: Compared with the baseline, MFNS significantly reduced the total and individual symptom scores and nocturnal sleep and daytime activities scores at week 1, 2, and 4 according to the Mini-RQLQ and NRQLQ.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2008]版:
大类 | 4 区 医学
小类 | 4 区 耳鼻喉科学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 耳鼻喉科学
JCR分区:
出版当年[2007]版:
Q3 OTORHINOLARYNGOLOGY
最新[2023]版:
Q3 OTORHINOLARYNGOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2007版] 出版当年五年平均 出版前一年[2006版] 出版后一年[2008版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Inst Otolaryngol, Beijing TongRen Hosp,Key Lab Otolaryngol Head & N, Dept Otolaryngol Head & Neck Surg,Minist Educ, Beijing 100005, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Inst Otolaryngol, Beijing TongRen Hosp,Key Lab Otolaryngol Head & N, Dept Otolaryngol Head & Neck Surg,Minist Educ, Beijing 100005, Peoples R China [*1]Beijing Institute of Otolaryngology, 17, HouGouHuTong, DongCheng District, Beijing 100005, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)